DongKook Pharmaceutical Co. Ltd (086450) — Cash Flow Quality Index
DongKook Pharmaceutical Co. Ltd (086450) has a Cash Flow Quality Index of 0.90x as of March 2026. Operating cash flow of ₩22.58 Billion is below net income of ₩24.95 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore DongKook Pharmaceutical Co. Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
DongKook Pharmaceutical Co. Ltd Cash Flow Quality Index (2013–2025)
Historical Cash Flow Quality Index for DongKook Pharmaceutical Co. Ltd across 13 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see 086450 cash flow metrics.
Annual Cash Flow Quality Index for DongKook Pharmaceutical Co. Ltd (2013–2025)
Year-by-year earnings quality comparison for DongKook Pharmaceutical Co. Ltd.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.04x | ₩68.76 Billion | ₩66.02 Billion | ▼ -16.2% |
| 2024 | 1.24x | ₩76.09 Billion | ₩61.22 Billion | ▲ +40.3% |
| 2023 | 0.89x | ₩41.79 Billion | ₩47.18 Billion | ▲ +14.5% |
| 2022 | 0.77x | ₩40.91 Billion | ₩52.90 Billion | ▼ -12.8% |
| 2021 | 0.89x | ₩44.65 Billion | ₩50.35 Billion | ▼ -14.0% |
| 2020 | 1.03x | ₩59.11 Billion | ₩57.29 Billion | ▼ -16.4% |
| 2019 | 1.23x | ₩69.48 Billion | ₩56.31 Billion | ▲ +74.4% |
| 2018 | 0.71x | ₩33.21 Billion | ₩46.95 Billion | ▼ -2.3% |
| 2017 | 0.72x | ₩28.66 Billion | ₩39.60 Billion | ▼ -25.3% |
| 2016 | 0.97x | ₩39.41 Billion | ₩40.69 Billion | ▼ -2.8% |
| 2015 | 1.00x | ₩27.14 Billion | ₩27.23 Billion | ▼ -7.5% |
| 2014 | 1.08x | ₩22.74 Billion | ₩21.10 Billion | ▼ -9.0% |
| 2013 | 1.18x | ₩19.86 Billion | ₩16.76 Billion | — |